Cargando…

Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects

Tumor recurrence from cancer stem cells (CSCs) and metastasis often occur post-treatment in colorectal cancer (CRC), leading to chemoresistance and resistance to targeted therapy. MYC is a transcription factor in the nuclei that modulates cell growth and development, and regulates immune response in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Tse-Hung, Mokgautsi, Ntlotlang, Huang, Yan-Jiun, Wu, Alexander T. H., Huang, Hsu-Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392328/ https://www.ncbi.nlm.nih.gov/pubmed/34440739 http://dx.doi.org/10.3390/cells10081970

Ejemplares similares

Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2023)

In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer
por: Chen, Lung-Ching, et al.
Publicado: (2023)

Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress Colorectal Cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2023)

Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent
por: Chinyama, Harold A., et al.
Publicado: (2023)

Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2022)

HNC0014, a Multi-Targeted Small-Molecule, Inhibits Head and Neck Squamous Cell Carcinoma by Suppressing c-Met/STAT3/CD44/PD-L1 Oncoimmune Signature and Eliciting Antitumor Immune Responses
por: Lee, Jih-Chin, et al.
Publicado: (2020)

Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines
por: Lawal, Bashir, et al.
Publicado: (2021)

Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling
por: Leung, Wai-Hung, et al.
Publicado: (2022)

Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of CCND1/CDK4/PLK1/CD44 in Cancer Types
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2021)

In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents
por: Chen, Yi-Fong, et al.
Publicado: (2023)

A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling
por: Wu, Alexander T. H., et al.
Publicado: (2021)

An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential GSK3β/β-Catenin/STAT3/CD44 Suppressor with Anti-Glioblastoma Properties
por: Mokgautsi, Ntlotlang, et al.
Publicado: (2021)

mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications
por: Lawal, Bashir, et al.
Publicado: (2021)

Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis
por: Lin, Shian-Ren, et al.
Publicado: (2020)

In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1
por: Khedkar, Harshita Nivrutti, et al.
Publicado: (2021)

Identification of Circular RNAs Associated With Chemoresistance in Colorectal Cancer
por: Yao, Fei, et al.
Publicado: (2021)

Transcriptomic-Based Identification of the Immuno-Oncogenic Signature of Cholangiocarcinoma for HLC-018 Multi-Target Therapy Exploration
por: Lawal, Bashir, et al.
Publicado: (2021)

Cancer Cell Membrane Biomimetic Mesoporous Nanozyme System with Efficient ROS Generation for Antitumor Chemoresistance
por: Tang, Wenxue, et al.
Publicado: (2022)

Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor
por: HUANG, RUI, et al.
Publicado: (2015)

Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas
por: Chen, Jungang, et al.
Publicado: (2019)

MicroRNA Methylome Signature and Their Functional Roles in Colorectal Cancer Diagnosis, Prognosis, and Chemoresistance
por: Baharudin, Rashidah, et al.
Publicado: (2022)

Integrative Multi-Omics Analysis of Oncogenic EZH2 Mutants: From Epigenetic Reprogramming to Molecular Signatures
por: Aldana, Julian, et al.
Publicado: (2023)

Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
por: Zou, Qian, et al.
Publicado: (2022)

Multi-Omics-Based Discovery of Plant Signaling Molecules
por: Luo, Fei, et al.
Publicado: (2022)

Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer
por: Sun, YuanLin, et al.
Publicado: (2022)

A novel hypoxic tumor microenvironment signature for predicting the survival, progression, immune responsiveness and chemoresistance of glioblastoma: a multi-omic study
por: Wang, Zihao, et al.
Publicado: (2020)

A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients
por: Gowrikumar, Saiprasad, et al.
Publicado: (2021)

Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer
por: Chen, Junliang, et al.
Publicado: (2023)

Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles
por: Shi, Cui, et al.
Publicado: (2023)

Research progress of traditional Chinese medicine as sensitizer in reversing chemoresistance of colorectal cancer
por: Lin, Xiang, et al.
Publicado: (2023)

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma
por: Li, Mei-Mei, et al.
Publicado: (2019)

A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance
por: Wang, Wei, et al.
Publicado: (2019)

Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives
por: Lawal, Bashir, et al.
Publicado: (2021)

Oxaliplatin-Induced DHX9 Phosphorylation Promotes Oncogenic Circular RNA CCDC66 Expression and Development of Chemoresistance
por: Lin, Ya-Chi, et al.
Publicado: (2020)

Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells
por: Jemaà, Mohamed, et al.
Publicado: (2020)

Comprehensive analysis of the prognostic and immunological signature of eight Tripartitemotif (TRIM) family molecules in human gliomas
por: Lu, Jiajie, et al.
Publicado: (2023)

Glutathione S-Transferase Alpha 4 Promotes Proliferation and Chemoresistance in Colorectal Cancer Cells
por: Zhang, Zhanhu, et al.
Publicado: (2022)

Classifying Integrated Signature Molecules in Macrophages of Rheumatoid Arthritis, Osteoarthritis, and Periodontal Disease: An Omics-Based Study
por: Sao, Prachi, et al.
Publicado: (2022)

Comprehensive analysis of the oncogenic and immunological role of SPON2 in human tumors
por: Tang, Jiali, et al.
Publicado: (2023)

LPCAT2 controls chemoresistance in colorectal cancer
por: Cotte, Alexia Karen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rc5bdcoq5lcbgbcjmmcrokqe96